Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
Phio Pharmaceuticals PHIO: This company which is focused on developing immuno-oncology therapeutics based on its proprietary self-delivering RNAi therapeutic platform, has seen the Zacks Consensus Estimate for its current year earnings increasing 14.4% over the last 60 days.

Phio Pharmaceuticals Corp. price-consensus-chart | Phio Pharmaceuticals Corp. Quote
Flex LNG FLNG: This shipping company which is focused on transportation of liquefied natural gas, has seen the Zacks Consensus Estimate for its current year earnings increasing 12.1% over the last 60 days.

Flex LNG Ltd. price-consensus-chart | Flex LNG Ltd. Quote
Bridgewater Bancshares BWB: This bank holding company which provides personal and commercial banking products and services to commercial real estate investors, small business entrepreneurs and high-net-worth individuals, has seen the Zacks Consensus Estimate for its current year earnings increasing 11.7% over the last 60 days.

Bridgewater Bancshares, Inc. price-consensus-chart | Bridgewater Bancshares, Inc. Quote
Alerus Financial ALRS: This financial services company, which offers banking, retirement and benefit services, wealth management and mortgage to businesses and consumers, has seen the Zacks Consensus Estimate for its current year earnings increasing 6.1% over the last 60 day.

Alerus Financial price-consensus-chart | Alerus Financial Quote
Halozyme Therapeutics HALO: This biopharmaceutical company which is focused on the development and commercialization of novel treatments for oncology indications by targeting tumor microenvironment, has seen the Zacks Consensus Estimate for its current year earnings increasing 4.4% over the last 60 days.

Halozyme Therapeutics, Inc. price-consensus-chart | Halozyme Therapeutics, Inc. Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
This article originally published on Zacks Investment Research (zacks.com).
| Sep-11 | |
| Sep-02 | |
| Sep-02 | |
| Aug-28 | |
| Aug-27 | |
| Aug-24 | |
| Aug-19 | |
| Aug-19 | |
| Aug-19 | |
| Aug-19 | |
| Aug-18 | |
| Aug-11 | |
| Aug-07 | |
| Aug-07 |
Why Halozyme, An IBD 50 Stock, Just Hit A Record High In Bullish Volume
HALO +20.24%
Investor's Business Daily
|
| Aug-07 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, alerts, and much more.
Learn more about Finviz Elite